BUZZ-Gilead up after settling patent litigations with some generic drugmakers
Reuters
Oct 06
BUZZ-<a href="https://laohu8.com/S/GILD">Gilead</a> up after settling patent litigations with some generic drugmakers
** Shares of drugmaker Gilead Sciences GILD.O climb 4.1% to $117.28 premarket
** Company says it resolved patent litigations with Indian drugmakers Lupin, Cipla and Laurus Labs, which had filed a marketing application for generic versions of GILD's HIV drug Biktarvy
** GILD says no generic entry of certain versions of the drug is expected prior to April 1, 2036 in the United States
** Up to last close, GILD shares up 22% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.